These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9550623)

  • 1. Progression of renal failure and lipids--is there evidence for a link in humans?
    Attman PO
    Nephrol Dial Transplant; 1998 Mar; 13(3):545-7. PubMed ID: 9550623
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid abnormality.
    Mune M; Otani H; Kimura K
    Contrib Nephrol; 2001; (134):55-62. PubMed ID: 11665288
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperglycemia and hyperlipidemia act synergistically to induce renal disease in LDL receptor-deficient BALB mice.
    Spencer MW; Mühlfeld AS; Segerer S; Hudkins KL; Kirk E; LeBoeuf RC; Alpers CE
    Am J Nephrol; 2004; 24(1):20-31. PubMed ID: 14671436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of altered lipid metabolism in the progression of renal disease: experimental evidence.
    Keane WF; Kasiske BL; O'Donnell MP; Kim Y
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):38-42. PubMed ID: 2024671
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased indoleamine 2,3-dioxygenase activity in type 2 diabetic nephropathy.
    Zhang Y; Ruan Y; Zhang P; Wang L
    J Diabetes Complications; 2017 Jan; 31(1):223-227. PubMed ID: 27646613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and classification of dyslipidemia in renal disease.
    Attman PO; Samuelsson O; Alaupovic P
    Blood Purif; 1996; 14(1):49-57. PubMed ID: 8718566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of intraglomerular hypertension and lipids in the development of diabetic nephropathy].
    Shestakova MV; Neverov NI; Dedov II
    Ter Arkh; 1993; 65(6):61-5. PubMed ID: 8378853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of inflammatory factors in risk assessment of renal insufficiency in diabetes mellitus].
    Ptasiński A; Paczek L
    Pol Arch Med Wewn; 2005 Jul; 114(1):695-701. PubMed ID: 16466018
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of diabetes mellitus on renal metabolism.
    Cortes P; Dumler F; Venkatachalam KK; Levin NW
    Miner Electrolyte Metab; 1983; 9(4-6):306-16. PubMed ID: 6197619
    [No Abstract]   [Full Text] [Related]  

  • 10. Proteinuria, albumin synthesis and hyperlipidaemia in the nephrotic syndrome.
    Kaysen GA; Don B; Schambelan M
    Nephrol Dial Transplant; 1991; 6(2):141-9. PubMed ID: 1857529
    [No Abstract]   [Full Text] [Related]  

  • 11. The link between mechanical stretch and glucose metabolism--a conceptual advance in understanding diabetic (and non diabetic?) renal disease.
    Gnudi L; Viberti G
    Nephrol Dial Transplant; 2007 Feb; 22(2):318-21. PubMed ID: 17114798
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy.
    Kim BH; Lee ES; Choi R; Nawaboot J; Lee MY; Lee EY; Kim HS; Chung CH
    Yonsei Med J; 2016 May; 57(3):664-73. PubMed ID: 26996567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of lipids in the progression of diabetic nephropathy.
    Krämer-Guth A; Quaschning T; Greiber S; Wanner C
    Clin Nephrol; 1996 Oct; 46(4):262-5. PubMed ID: 8905213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney Disease.
    Gilbert RE
    Diabetes; 2017 Apr; 66(4):791-800. PubMed ID: 28325740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renal archaeologist: digging for clues in archived tissues to understand diabetic kidney disease.
    Long DA; Lennon R
    Nephrol Dial Transplant; 2012 May; 27(5):1693-5. PubMed ID: 22337901
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum lipids in renal insufficiency.
    Heuck CC; Ritz E; Liersch M; Mehls O
    Am J Clin Nutr; 1978 Sep; 31(9):1547-53. PubMed ID: 210650
    [No Abstract]   [Full Text] [Related]  

  • 17. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy.
    Takahashi T; Konta T; Takasaki S; Ichikawa K; Takeishi Y; Kubota I
    Clin Exp Nephrol; 2007 Sep; 11(3):202-208. PubMed ID: 17891346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causes of renal failure in patients with type 2 diabetes mellitus.
    Kida Y
    JAMA; 2003 Oct; 290(14):1855; author reply 1855-6. PubMed ID: 14532311
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipids and progressive renal failure.
    Keane WF; Guijarro C
    Contrib Nephrol; 1996; 118():17-23. PubMed ID: 8744035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.